Health Secretary Robert F. Kennedy Jr. announced plans to help people wean off antidepressants at a MAHA Institute event on Monday. Kennedy has been critical of psychiatric medications and their side effects. Mental health advocates and psychiatrists emphasize the complexity of the mental health crisis in the U.S. and stress the importance of access to timely, comprehensive care.
While the American Psychiatric Association supports plans to train healthcare providers on safely prescribing and weaning off antidepressants, they caution against oversimplifying the issue. Kennedy’s initiative includes new training, clinical guidance, and insurance billing changes to support providers helping patients stop antidepressants like Prozac and Zoloft.
The Department of Health and Human Services acknowledges the role of psychiatric medications but encourages providers to consider alternatives and involve patients in decision-making. Kennedy plans to release more data on prescribing trends and clinical guidance in the future.
Dr. Vera Feuer, a child and adolescent psychiatrist, agrees with the push for evidence-based care and therapies. She emphasizes the importance of careful assessment before prescribing medications and supports medically supervised tapering when stopping SSRIs.
The American Foundation for Suicide Prevention highlights the efficacy of antidepressants in treating depression and reducing suicide risk. They emphasize the need for judicious use based on scientific evidence.
:fill(black)/2026/05/05/69f9b43713385978551602.jpg "A formidable match to play: Antoine Griezmann one step away from a last final")